IP Library Granted Patent US 8,083,997
Granted Patent B2
US 8,083,997 · App. 12/500,929 · Granted Dec 27, 2011

Conversion of nitrogen dioxide (NO

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,083,997
App. No.
12/500,929
Granted
Dec 27, 2011
Kind
B2
Abstract

Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. A nitric oxide delivery system that converts nitrogen dioxide to nitric oxide employs a surface-active material, such as silica gel, coated with an aqueous solution of antioxidant, such as ascorbic acid.

Claims (24)

1. An apparatus for converting nitrogen dioxide to nitric oxide comprising a receptacle including an inlet, an outlet and an antioxidant, wherein the inlet is configured to receive a gas flow comprising nitrogen dioxide and fluidly communicate the gas flow through the receptacle to the outlet, such that the gas flow contacts the antioxidant inside the receptacle, and the antioxidant converts the nitrogen dioxide in the gas flow to nitric oxide.

2. The apparatus of claim 1 , wherein the receptacle further comprises a surface-active material.

3. The apparatus of claim 2 , wherein the surface-active material comprises a substrate that retains water.

4. The apparatus of claim 2 , wherein the surface-active material comprises a silica gel.

5. The apparatus of claim 2 , wherein the antioxidant is included on the surface active material.

6. The apparatus of claim 1 , wherein the receptacle comprises a cartridge.

7. The apparatus of claim 1 , wherein the antioxidant comprises ascorbic acid, alpha tocopherol or gamma tocopherol.

8. An apparatus for generating a therapeutic gas including nitric oxide for use in delivering the therapeutic gas to a mammal comprising:

a permeation cell having liquid nitrogen dioxide and capable of diffusing gaseous nitrogen dioxide into a gas flow; and

a receptacle including an inlet, an outlet and an antioxidant, wherein the inlet is configured to receive the gas flow comprising nitrogen dioxide and fluidly communicate the gas flow through the receptacle to the outlet, such that the gas flow contacts the antioxidant inside the receptacle, and the antioxidant converts the nitrogen dioxide in the gas flow to nitric oxide.

9. The apparatus of claim 8 , wherein the receptacle is a first receptacle, the apparatus further comprising a second receptacle including a second inlet, a second outlet and a second antioxidant, wherein the second inlet is configured to receive the gas flow comprising nitrogen dioxide and fluidly communicate the gas flow through the receptacle to the second outlet, such that the gas flow contacts the second antioxidant inside the second receptacle, and the second antioxidant converts the nitrogen dioxide in the gas flow to nitric oxide.

10. The apparatus of claim 9 , wherein the antioxidant in the first receptacle and the second antioxidant are the same.

11. The apparatus of claim 9 , wherein the second receptacle further comprises a second suface-active material.

12. The apparatus of claim 11 , wherein the surface-active material in the first receptacle and the second surface-active material are the same.

13. The apparatus of claim 9 , further comprising a flexible bag operable to inflate and deflate as the mammal breathes, and wherein the second receptacle is positioned between the flexible bag and a point at which the gas flow including nitric oxide is delivered to the mammal.

14. The apparatus of claim 8 , wherein the receptacle further comprises a surface-active material.

15. The apparatus of claim 14 , wherein the surface-active material comprises a substrate that retains water.

16. The apparatus of claim 14 , wherein the surface-active material comprises a silica gel.

17. The apparatus of claim 14 , wherein the antioxidant is on the surface active material.

18. The apparatus of claim 8 , further comprising an air pump capable of generating the gas flow, wherein the permeation cell is configured to receive the gas flow generated by the air pump.

19. The apparatus of claim 18 , wherein the air pump is portable.

20. The apparatus of claim 8 , further comprising an oxygen-enrichment device capable of supplying oxygen in the gas flow, wherein the permeation cell is configured to receive the gas flow enriched by the oxygen-enrichment device.

21. The apparatus of claim 8 , wherein the receptacle comprises a cartridge.

22. The apparatus of claim 8 , wherein the antioxidant comprises ascorbic acid, alpha tocopherol or gamma tocopherol.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Mar 18, 2026
From: HORIZON TECHNOLOGY FINANCE CORPORATION
To: VERO BIOTECH INC.
Reel/Frame 075308/0198 →
SECURITY INTEREST Recorded Mar 16, 2026
From: VERO BIOTECH INC.
To: SYMBIOTIC CAPITAL AGENCY LLC, AS COLLATERAL AGENT
Reel/Frame 075117/0935 →
TERMINATION AND RELEASE OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jan 3, 2024
From: RUNWAY GROWTH FINANCE CORP (F/K/A RUNWAY GROWTH CREDIT FUND INC.)
To: VERO BIOTECH INC. (F/K/A VERO BIOTECH LLC)
Reel/Frame 066186/0611 →
SECURITY INTEREST Recorded Jan 3, 2024
From: VERO BIOTECH INC.
To: HORIZON TECHNOLOGY FINANCE CORPORATION
Reel/Frame 066187/0865 →
CHANGE OF NAME Recorded Feb 14, 2022
From: VERO BIOTECH LLC
To: VERO BIOTECH INC.
Reel/Frame 059085/0418 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 1, 2021
From: ROUNBEHLER, DAVID P.; FINE, DAVID H.
To: CYTERRA CORPORATION
Reel/Frame 057360/0091 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 1, 2021
From: CYTERRA CORPORATION
To: GENO LLC
Reel/Frame 057360/0096 →
SECURITY INTEREST Recorded Dec 29, 2020
From: VERO BIOTECH LLC
To: RUNWAY GROWTH CREDIT FUND INC.
Reel/Frame 054866/0589 →
CHANGE OF NAME Recorded Jun 6, 2018
From: GENO LLC
To: VERO BIOTECH LLC
Reel/Frame 046304/0855 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 15, 2011
From: ROUNBEHLER, DAVID P.; FINE, DAVID H.
To: GENO LLC
Reel/Frame 027227/0610 →